Skip to main content

TAKHZYRO

NDC 47783-644 · Takeda Pharmaceuticals America, Inc.

Generic namelanadelumab-flyo
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)LANADELUMAB
Strength300 mg/2mL
Pharmacologic classKallikrein Inhibitors [MoA], Plasma Kallikrein Inhibitor [EPC]
Marketing categoryBLA

Packages

47783-644-01 — 1 VIAL, GLASS in 1 CARTON (47783-644-01) / 5 mL in 1 VIAL, GLASS

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

47783-645 — lanadelumab-flyo, 47783-646 — lanadelumab-flyo

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.